Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT03160430
What this trial is testing

A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Resverlogix Corp 44
Not applicableUnknownNCT04389528
What this trial is testing

Evaluation of the Effect of tDCS on Cannabis Craving

Who this might be right for
Addiction to Cannabis
Januel 78
Testing effectiveness (Phase 2)Study completedNCT01006265
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 464
Large-scale testing (Phase 3)Ended earlyNCT00718965
What this trial is testing

Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Sanofi 826
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT02696434
What this trial is testing

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

Who this might be right for
Opioid Use Disorder
Alkermes, Inc. 101
Early research (Phase 1)Study completedNCT04707131
What this trial is testing

Single Ascending Dose of LEM-S401 in Healthy Participants

Who this might be right for
CicatrixScar Prevention
Lemonex Inc. 19
Post-approval studies (Phase 4)Study completedNCT01534195
What this trial is testing

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Who this might be right for
Allergic Conjunctivitis
ORA, Inc. 11
Large-scale testing (Phase 3)UnknownNCT05895877
What this trial is testing

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Who this might be right for
Constipation
Synmosa Biopharma Corp. 351
Testing effectiveness (Phase 2)Study completedNCT00577577
What this trial is testing

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Insmed Incorporated 69
Early research (Phase 1)Study completedNCT04926701
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Enterprise Therapeutics Ltd 98
Early research (Phase 1)Active Not RecruitingNCT07310901
What this trial is testing

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

Who this might be right for
Obese But Otherwise Healthy Participants
Corbus Pharmaceuticals Inc. 252
Testing effectiveness (Phase 2)Study completedNCT04523181
What this trial is testing

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Who this might be right for
Covid-19
Golden Biotechnology Corporation 124
Testing effectiveness (Phase 2)Study completedNCT00313300
What this trial is testing

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS)
Bristol-Myers Squibb 1,741
Early research (Phase 1)Temporarily pausedNCT06739707
What this trial is testing

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

Who this might be right for
Healthy Volunteer
Cohen Global, Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01733407
What this trial is testing

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Who this might be right for
Hereditary Sensory and Autonomic Neuropathy Type I
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT06147544
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Who this might be right for
Obesity
PegBio Co., Ltd. 36
Early research (Phase 1)Not Yet RecruitingNCT07557602
What this trial is testing

MRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

Who this might be right for
EBV
Vaccine Company, Inc. 45
Large-scale testing (Phase 3)Study completedNCT01503957
What this trial is testing

Nasya in Allergic Rhinitis

Who this might be right for
Allergic Rhinitis
InQpharm Group 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation